CS
IBIO icon

Credit Suisse’s iBio IBIO Stock Holding History

Credit Suisse’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– – – 4143
2022
Q2 		– Sell
-38
Closed -$5.71K – 4101
2022
Q1 		$8K Sell
38
-23
-38% -$4.81K ﹤0.01% 3548
2021
Q4 		$16K Buy
+61
New +$23.3K ﹤0.01% 4455
2021
Q2 		– Sell
-50
Closed -$39K – 4519
2021
Q1 		$39K Sell
50
-50
-50% -$43.6K ﹤0.01% 4242
2020
Q4 		$52K Buy
+100
New +$81.5K ﹤0.01% 4252

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse's IBIO Position: Q3 2022 in Review

Credit Suisse held its iBio (IBIO) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4143.

Credit Suisse first reported a position in IBIO in Q4 2020 and has held it in 4 quarters since. The position peaked at $52K in Q4 2020. 43 funds tracked by Wall St. Rank hold IBIO as of Q3 2022.

  • Credit Suisse held 0 shares of iBio worth $0 as of Q3 2022.
  • Credit Suisse left its iBio share count unchanged in Q3 2022.
  • iBio made up ﹤0.01% of Credit Suisse's portfolio in Q3 2022, its #4143 holding.
  • Credit Suisse first reported a position in iBio in Q4 2020 and has held it in 4 quarters since.
  • Credit Suisse's iBio position peaked at $52K in Q4 2020.
  • 43 funds tracked by Wall St. Rank held iBio as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.